Thomas Arnesen Selected Research

Aldosterone

1/2021	X-chromosome variants are associated with aldosterone producing adenomas.
11/2019	A somatic mutation in CLCN2 identified in a sporadic aldosterone-producing adenoma.
2/2014	Complementary somatic mutations of KCNJ5, ATP1A1, and ATP2B3 in sporadic aldosterone producing adrenal adenomas.
8/2013	Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Arnesen Research Topics

Disease

7	Neoplasms (Cancer) 01/2015 - 10/2005
5	Intellectual Disability (Idiocy) 01/2023 - 11/2015
5	Inborn Genetic Diseases (Disease, Hereditary) 01/2023 - 07/2011
4	Adenoma (Adenomas) 01/2021 - 08/2013
3	Microcephaly 11/2021 - 01/2016
3	Hypoxia (Hypoxemia) 11/2005 - 03/2005
2	Hereditary Sensory and Autonomic Neuropathies (HSAN) 03/2012 - 04/2006
2	Thyroid Neoplasms (Thyroid Cancer) 12/2010 - 10/2005
2	Carcinogenesis 10/2005 - 03/2005
1	Movement Disorders (Movement Disorder) 03/2024
1	Cognitive Dysfunction 03/2024
1	Heart Diseases (Heart Disease) 01/2023
1	Type 3 Maturity-Onset Diabetes of the Young 01/2022
1	Congenital Hyperinsulinism 01/2021
1	Hyperaldosteronism (Conn Syndrome) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Familial Hyperaldosteronism 11/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Starvation 12/2018
1	Neurodevelopmental Disorders 01/2018
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2018
1	Separation Anxiety (Separation Anxiety Disorder) 12/2016
1	Hyperplasia 08/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2009
1	Lung Neoplasms (Lung Cancer) 11/2008
1	Melanoma (Melanoma, Malignant) 12/2006
1	Papillary Carcinoma 10/2005
1	Papillary Thyroid Cancer 10/2005
1	Glioma (Gliomas) 03/2005

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2005
6	N-acetyltryptophanamide (NATA)IBA 12/2018 - 04/2006
6	N-Terminal AcetyltransferasesIBA 12/2016 - 04/2006
5	N-acetyltalosaminuronic acid (NAT)IBA 01/2023 - 03/2005
5	AcetyltransferasesIBA 01/2019 - 03/2005
4	AldosteroneIBA 01/2021 - 08/2013
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 03/2005
2	EnzymesIBA 01/2023 - 10/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2013
2	protein N-terminal acetyltransferaseIBA 11/2021 - 03/2012
1	CalciumIBA 03/2024
1	Glutamate DehydrogenaseIBA 01/2021
1	Chloride Channels (Chloride Channel)IBA 11/2019
1	SynucleinsIBA 01/2019
1	GlycogenIBA 12/2018
1	ChromatinIBA 01/2015
1	RacivirIBA 12/2010
1	Daunorubicin (Cerubidine)FDA LinkGeneric 12/2010
1	Troglitazone (Rezulin)FDA Link 12/2010
1	Fluorouracil (Carac)FDA LinkGeneric 09/2009
1	Cyclin D1IBA 11/2008
1	beta CateninIBA 11/2008
1	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2006
1	TransferasesIBA 10/2005
1	AntibodiesIBA 10/2005
1	Messenger RNA (mRNA)IBA 10/2005